Loading...
Novel Drugs in Follicular Lymphoma
Follicular lymphoma(FL) is the most common indolent non-Hodgkin lymphoma and constitutes 15% to 30% of lymphoma diagnoses. The natural history of the disease is characterized by recurrent relapses and progressively shorter remissions with a median survival of 10yrs. The impossibility of achieving a...
Saved in:
| Published in: | Mediterr J Hematol Infect Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Università Cattolica del Sacro Cuore
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5111511/ https://ncbi.nlm.nih.gov/pubmed/27872741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2016.061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|